Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Gynecology

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 122 articles: HTML format

Single Articles

October 2023
1. HAN K, Leung E
   Opinion "POLE": Considering All Factors in Early-Stage Endometrial Cancer.
   Int J Radiat Oncol Biol Phys. 2023;117:299-300.
   PubMed    
   
   
   
2. MATANI H, Beriwal S
   Interplay Between Anatomic and Molecular Factors in the Current Management of Endometrial Cancer.
   Int J Radiat Oncol Biol Phys. 2023;117:298.
   PubMed    
   
   
   September 2023
3. KUNZ JN, Huang YJ, Casper AC, Suneja G, et al
   Dosimetric Evaluation of Organs at Risk From SAVE Protocol.
   Int J Radiat Oncol Biol Phys. 2023;117:274-280.
   PubMed     Abstract available
   
   
   
4. CHO WK, Kim HS, Park W, Kim YS, et al
   The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
   Int J Radiat Oncol Biol Phys. 2023;117:154-163.
   PubMed     Abstract available
   
   
   August 2023
5. COLSON-FEARON D, Stone R, Viswanathan AN
   Risk factors and survival impact associated with documentation of radiation therapy refusal in gynecologic cancer patients.
   Int J Radiat Oncol Biol Phys. 2023 Aug 30:S0360-3016(23)07851.
   PubMed     Abstract available
   
   
   
6. LAVILLE A, Ka K, El-Ayachi R, Achkar S, et al
   Locoregional treatment in patients with metastatic cervical cancer: benefit of dose escalation strategies.
   Int J Radiat Oncol Biol Phys. 2023 Aug 14:S0360-3016(23)07744.
   PubMed     Abstract available
   
   
   July 2023
7. KUMAR A, Gurram L, Nayak P, Mulye G, et al
   Correlation of haematological parameters with clinical outcomes in cervical cancer patients treated with radical radio (chemo) therapy - A retrospective study.
   Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07677.
   PubMed     Abstract available
   
   
   June 2023
8. LIN LL, Msadabwe SC, Chiao E
   Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer.
   Int J Radiat Oncol Biol Phys. 2023;116:459-462.
   PubMed    
   
   
   
9. LIN LL, Ndlovu N, Lowenstein J, Wirth M, et al
   Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.
   Int J Radiat Oncol Biol Phys. 2023;116:439-447.
   PubMed     Abstract available
   
   
   May 2023
10. MACCHIA G, Pezzulla D, Campitelli M, Laliscia C, et al
    EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC UTERINE CANCER (MITO-RT2/RAD STUDY): A LARGE, REAL-WORLD STUDY IN COLLABORATION WITH AIRO GYN, MITO and MaNGO Groups.
    Int J Radiat Oncol Biol Phys. 2023 May 5:S0360-3016(23)00417.
    PubMed     Abstract available
    
    
    April 2023
11. MARAR M, Niedermayr T, Kidd E
    Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency.
    Int J Radiat Oncol Biol Phys. 2023 Apr 12:S0360-3016(23)00364.
    PubMed     Abstract available
    
    
    
12. LI B, Hirata E, Trejo JM, Garcia B, et al
    Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2023;115:1205-1216.
    PubMed    
    
    
    March 2023
13. KOK HP, Herrera TD, Crezee J
    The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
    Int J Radiat Oncol Biol Phys. 2023;115:994-1003.
    PubMed     Abstract available
    
    
    
14. PIFER PM, Jaishankar S, Bhargava R, Schad MD, et al
    Is substantial LVSI prognostic in patients with pathologically lymph node-negative endometrial cancer?
    Int J Radiat Oncol Biol Phys. 2023 Mar 7:S0360-3016(23)00214.
    PubMed     Abstract available
    
    
    February 2023
15. SAMMOURI J, Wong MC, Lynn EJ, El Alam MB, et al
    Serial genotyping of the human papillomavirus in cervical cancer: an insight into virome dynamics during chemoradiation therapy.
    Int J Radiat Oncol Biol Phys. 2023 Feb 16:S0360-3016(23)00163.
    PubMed     Abstract available
    
    
    
16. HATHOUT L, Fields EC, Erickson BA
    Stereotactic Body Radiation Therapy for Nodal Metastases in Gynecologic Cancers: Is it the Swan Song or the Opening Number?
    Int J Radiat Oncol Biol Phys. 2023;115:297-301.
    PubMed    
    
    
    
17. CORRADINI S, Seidensticker M
    "New" Kid on the Block: Interstitial Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2023;115:277-279.
    PubMed    
    
    
    
18. HARKENRIDER M, Fields E, Chopra S, Damast S, et al
    Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:269-275.
    PubMed    
    
    
    January 2023
19. ARIANS N, Lindel K, Krisam J, Oelmann-Avendano JT, et al
    Treatment tolerability and toxicity of postoperative proton beam therapy for gynecological malignancies - results of the prospective phase II APROVE-trial.
    Int J Radiat Oncol Biol Phys. 2023 Jan 12:S0360-3016(23)00012.
    PubMed     Abstract available
    
    
    
20. VITTRUP AS, Kirchheiner K, Potter R, Fokdal LU, et al
    Overall severe morbidity after chemo-radiotherapy and MRI guided adaptive brachytherapy in locally advanced cervical cancer: results from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00007.
    PubMed     Abstract available
    
    
    November 2022
21. JIANG P, Deng X, Qu A, Jiang W, et al
    Image-guidance volume modulated arc radiotherapy concurrently with Nab-paclitaxel plus cisplatin for patients with locally advanced cervical cancer: a single-arm dose escalation trial.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03522.
    PubMed     Abstract available
    
    
    
22. MA J, Lee NY
    What to Expect When You're Expecting: Managing Oral Cavity Cancer in the Setting of a Second Trimester Pregnancy.
    Int J Radiat Oncol Biol Phys. 2022;114:383-384.
    PubMed    
    
    
    
23. SHARMA AK
    Adjuvant Head and Neck Radiation in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022;114:382.
    PubMed    
    
    
    October 2022
24. YODER AK, Dong E, Yu X, Echeverria A, et al
    Impact of Quality of Life on Radiation Adherence for Cervical Cancer Patients in an Urban Safety Net Health System.
    Int J Radiat Oncol Biol Phys. 2022 Oct 10. pii: S0360-3016(22)03439.
    PubMed     Abstract available
    
    
    September 2022
25. KAMRAVA M, Leung E, Bachand F, Beriwal S, et al
    GEC-ESTRO (ACROP) - ABS - CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina.
    Int J Radiat Oncol Biol Phys. 2022 Sep 30. pii: S0360-3016(22)03396.
    PubMed     Abstract available
    
    
    
26. MARAR M, Simiele E, Niedermayr T, Kidd EA, et al
    Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
    Int J Radiat Oncol Biol Phys. 2022;114:111-119.
    PubMed     Abstract available
    
    
    August 2022
27. JACOBSON GM, Bajaj GK, Buatti JM, Dawson L, et al
    ASTRO supports access to evidence-based cancer care for all patients, regardless of pregnancy status, and protection for physicians recommending and providing evidence-based care.
    Int J Radiat Oncol Biol Phys. 2022 Aug 9. pii: S0360-3016(22)02602.
    PubMed    
    
    
    
28. CHINO J, Yashar C, Klopp A, Viswanathan A, et al
    Limiting Access to Abortion will Potentially Harm Patients with Gynecologic Cancers.
    Int J Radiat Oncol Biol Phys. 2022 Aug 9. pii: S0360-3016(22)02600.
    PubMed    
    
    
    
29. EVANS SB, Blitzblau RC, Chapman CH, Lipscomb CC, et al
    Restricted Access to Abortion, the Dobbs Ruling, and Radiation Oncology: Standing United Against Reproductive Injustice.
    Int J Radiat Oncol Biol Phys. 2022 Aug 9. pii: S0360-3016(22)02598.
    PubMed    
    
    
    
30. MULANI J, Jain J, Gupta A, Swamidas J, et al
    Dose Accumulation for Multicourse Gynecological Reirradiation: A Methodological Narrative and Clinical Examples.
    Int J Radiat Oncol Biol Phys. 2022;113:1085-1090.
    PubMed     Abstract available
    
    
    July 2022
31. BARRY P, Beriwal S
    Combination of Knife and Rays with MRI-Guided Ablative Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2022;113:717-718.
    PubMed    
    
    
    
32. CHOPRA S, Kalra B, Mulani J, Jain J, et al
    Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 15. pii: S0360-3016(22)00722.
    PubMed     Abstract available
    
    
    June 2022
33. GOUVEIA AG, Viani GA, Bratti VF, Pavoni JF, et al
    System-level capacity of high dose rate (HDR) brachytherapy for management of cervical cancer in an upper middle-income country: a case study from Brazil.
    Int J Radiat Oncol Biol Phys. 2022 Jun 29. pii: S0360-3016(22)00624.
    PubMed     Abstract available
    
    
    
34. RICH BJ, Montoya C, Jin WH, Spieler BO, et al
    Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 4. pii: S0360-3016(22)00545.
    PubMed     Abstract available
    
    
    March 2022
35. KIDD E, Harkenrider M, Damast S, Fields E, et al
    Improving Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:841-848.
    PubMed    
    
    
    February 2022
36. MITTAL P, Chopra S, Charnalia M, Dora T, et al
    Patterns of relapse after adjuvant (chemo)radiation for cervical cancer in a phase III clinical trial (PARCER): an evaluation of updated NRG Oncology /RTOG target delineation guidelines.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00153.
    PubMed     Abstract available
    
    
    
37. LINDEGAARD JC, Petric P, Schmid MP, Nesvacil N, et al
    Prognostic implications of uterine cervical cancer regression during chemoradiation evaluated by the T-score in the multicenter XXX study.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00151.
    PubMed     Abstract available
    
    
    
38. DAMAST S, Chino J
    Secondary Prevention, Not Secondary Importance: Embracing Survivorship Concerns and HRT After Cervical Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:414-416.
    PubMed    
    
    
    January 2022
39. WILLIAMSON CW, Sirak I, Xu R, Portelance L, et al
    Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.
    Int J Radiat Oncol Biol Phys. 2022;112:169-178.
    PubMed     Abstract available
    
    
    November 2021
40. SMET S, Spampinato S, Potter R, Jurgenliemk-Schulz IM, et al
    Risk factors for late persistent fatigue after chemoradiotherapy in locally advanced cervical cancer: an analysis from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2021 Nov 25. pii: S0360-3016(21)03220.
    PubMed     Abstract available
    
    
    
41. WANG X, Ouyang G, Chen Z, Fu L, et al
    Automatic Contouring of the Clinical Target Volume (CTV) for Cervical Cancer Adjuvant Radiotherapy Using Deep Learning Algorithm.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
42. KAWAHARA D, Nishibuchi I, Kawamura M, Yoshida T, et al
    Radiomic Analysis for Pretreatment Prediction of Recurrence after Radiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
43. HAMADE DF, Epperly M, Fisher R, Hou W, et al
    Second-Generation Probiotic Lactobacillus Reuteri Producing IL-22 (LR-IL-22) Protects the Intestine to Facilitate Whole Abdomen Irradiation (WAI) in Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
44. YU E, DiPetrillo TA, Koffer PP, Miller CJ, et al
    Hospital Database Validation of PORTEC3 Stage-Based Overall Survival Benefit for Chemoradiation Therapy in Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
45. WEIL C, Lew F, Gaffney DK, Suneja G, et al
    Patterns of Practice for Adjuvant Treatment of FIGO 1B Grade 3 Endometrial Adenocarcinoma Following Publication of ASTRO 2014 Guidelines for Postoperative Treatment in Women With Early Stage High Risk Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
46. WANG W, Zou L, Wang T, Liu Z, et al
    Treatment Optimization of Pelvic External Beam Radiation With/or Vaginal Brachytherapy for Patients with Stage I to II High-Risk Endometrioid Adenocarcinoma: A Retrospective Multi-Institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
47. SUN S, Zou L, Wang T, Liu Z, et al
    Age >/=60 y May Not be an Appropriate Adverse Risk Factor in Adjuvant Treatment of Patients With Early-Stage Endometrial Carcinoma: A Multi-Institutional Analysis in China.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
48. RUSSO AL, Bernstein KD, Nisbet SP, Horick N, et al
    Phase II Study of Adjuvant Scanned Proton Beam Radiation Therapy for Node-positive Cancer of the Uterus and Cervix.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
49. REN K, Zou L, Wang T, Li X, et al
    Long-Term Outcome and Failure Patterns in Early-Stage Endometrial Cancer After Postoperative Adjuvant Radiotherapy: A Multi-Institutional Analysis Update Data.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
50. PATEL G, Rivera A, Brodin P, Velten C, et al
    Outcomes of Definitive Radiation Therapy for Inoperable Endometrial Cancer and Dosimetric Comparison Study of HDR Brachytherapy vs. SBRT Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
51. NGANGA D, Hoover A
    Visceral Adipose Volume as a Predictor for Acute Bowel Toxicity in Patients Receiving Adjuvant Intensity-Modulated Radiation Therapy for Cervical or Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
52. IKIZLER O, Ko HC
    Outcomes after Definitive Surgery +/- Adjuvant Treatment for Invasive and Non-Invasive FIGO Stage IA Malignant Mixed Mullerian Tumor of the Endometrium.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
53. HUI C, Mendoza M, Von Eyben R, Hammer P, et al
    Does Lymph Node Assessment Change the Prognostic Significance of Extensive LVSI and p53 Mutation in Endometrial Cancer?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
54. MERFELD E, Huang JY, Kuczmarska-Haas A, Desai V, et al
    Targeting the GTV in Medically Inoperable Endometrial Cancer Using Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
55. COOK AE, Ghanem AI, Hijaz M, Burmeister C, et al
    Patterns of Recurrence After Adjuvant Vaginal Cuff Brachytherapy and Chemotherapy in Early-Stage Uterine Serous Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
56. BYLUND KC, Chowdhry AK, Nguyen K, Geevarghese S, et al
    Effect of Adjuvant Radiation and Chemotherapy in Localized Uterine Carcinosarcoma: A National Cancer Database Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
57. CASPER AC, Parsons MW, Chipman J, Burt LM Jr, et al
    Risk of Secondary Malignancies in Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years of Follow-up.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
58. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
    Pathologic Primary Tumor Factors Associated With Risk of Lymph Node Involvement in Patients With High-Risk Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
59. POLLOCK AE, Risher H, Bentzen SM, Roque DM, et al
    Clinical Outcomes of Patients Treated With Intensity Modulated Proton Therapy (IMPT) Re-Irradiation for Gynecologic Malignancies.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
60. CORRIGAN KL, Yoder AK, Lin LL, Jhingran A, et al
    Long-Term Survival Following Definitive Radiation Therapy for Oligometastases in Gynecological Malignancies: A Landmark Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
61. ZHOU Z, Zhang F, Hu K
    High Dose Radiotherapy Combined With TGF-beta Blocking Alleviate Cervical Cancer Cell-Suppressed Dendritic Cell Homing Through PGE2 Pathway.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
62. AMARNATH SR
    Is Inflammatory Bowel Disease a Contraindication for Pelvic XRT in Patients With Gynecologic Cancers? Efficacy and Toxicity Outcomes in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
63. YANG H, Zhang Y, Liu C, Zhao L, et al
    Combined Modality of Bevacizumab With Radical Radiotherapy and Chemotherapy in the Treatment of Refractory Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
64. WU J, Lakomy DS, Fellman B, Salcedo MP, et al
    Bone Mineral Density Changes Within and Outside of RT Fields Used to Treat Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
65. WILLIAMSON CW, Kotha NV, Morris K, Simoes-Torigoe R, et al
    Radiation-Induced Vaginal Stenosis in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
66. WEIL C, Parsons MW, Chipman J, Kraus RD, et al
    Secondary Malignancy Risk in Cervical Cancer Survivors After 40 Years of Follow-Up Stratified by Treatment Modality and Radiation Technique.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
67. WANG D, Hu K, Zhang F
    Impact of Body Mass Index and Abdominal Subcutaneous Fat Thickness of Setup Errors in Postoperative Cervical Cancer Patients Underwent Daily Image-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
68. WEI C, Franco II, Orio PF 3rd, Mak RH, et al
    Comparison of Cost vs. Reimbursement for Definitive Radiotherapy in Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
69. THOMAS RJ, Provenzano D, Goyal S, Loew M, et al
    Trends in Guideline-Adherent Chemoradiation Therapy for Locally Advanced Cervical Cancer Before and After the Affordable Care Act.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
70. SAITO AI
    Curative Radiotherapy for Stage IVB or Recurrent Uterine Cancer Presenting With Supraclavicular or Mediastinal Lymph Node Metastasis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
71. SHI V, Huang Y, Grigsby PW, Markovina S, et al
    Serum SCCA as an Early Indicator of Recurrence in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
72. RAHIMY E, Von Eyben R, Lewis J, Hristov DH, et al
    Dosimetric and Metabolic Parameters Predictive of Hematologic Toxicity in Cervical Cancer Patients Undergoing Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
73. PINTO PJJ, Favareto SL, Souza CFPM, Baiocchi G, et al
    Do Radiotherapy Planning Factors Influence Para-Aortic Recurrence in IIIC1 Cervical Cancer Patients?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
74. PACHIGOLLA SL, Markovina S, Lin AJ, Schwarz JK, et al
    Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Cervical Cancer Not Amenable to Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
75. ONAL C, Guler OC, Reyhan M, Yapar AF, et al
    Long-Term Outcomes of Cervical Cancer Patients With Complete Metabolic Response After Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
76. PACHIGOLLA SL, Massad LS, Thaker P, Mutch D, et al
    A Nomogram Predicting Early Cervical Cancer Distant Recurrence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
77. OKONOGI N, Ando K, Murata K, Wakatsuki M, et al
    The Clinical Results in Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients With Locally Advanced Adenocarcinoma of the Uterine Cervix.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
78. NISHIBUCHI I, Kawahara D, Kawamura M, Kubo K, et al
    A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
79. PUENTES CYM, Banks T, Hrycushko BA, Jia X, et al
    Multidisciplinary Consensus and Evaluation of Gynecological High-Dose-Rate (HDR) Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
80. LIU C, Li A, Wang C, Zou W, et al
    Intratumor Microbiome and Its Correction With Tumor Response After Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
81. LI F, Li J, Yin S, Mei F, et al
    A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump >/=4 cm).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
82. LI J, Mao W, Li F, Ran L, et al
    A Phase II, Single-Arm, Prospective Clinical Trial for the Efficacy and Safety of Apatinib Combined With Capecitabine in Therapy for Recurrent/Metastatic and Persistent Cervical Cancer After Radiochemotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
83. KOTHA NV, Williamson CW, McHale M, Mell LK, et al
    Ineligible and Incomplete Cisplatin Regimens in Chemoradiation Treatment for Patients With Locally Advanced Cervical Cancer: A Population for Survival Improvement.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
84. LEE TH, Kim IA, Kim JS Jr, Song C, et al
    Stereotactic Ablative Body Radiotherapy Boost for Cervical Cancer When Brachytherapy Boost is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
85. KIM KH, Chang JS, Kim YB
    A Novel Gene Signature Associated With Poor Response to Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
86. KOERNER SA, Baig T, Kim H, Rodriguez-Lopez JL, et al
    Can We Avoid Ureters as Organs at Risk With MRI-Based Brachytherapy for Cervical Cancer? A Dosimetric Feasibility Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
87. GJYSHI O, Grippin A, Boyce-Fappiano D, Jhingran A, et al
    Circulating and Tumor-Associated Neutrophils Function as a Powerful Biomarker for Response to Chemoradiation in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
88. HOLLIS ES, Ruebush E, Davies E, Paraghamian S, et al
    Smoking Cessation Interventions During Chemoradiotherapy for Locally Advanced Cervical Cancer: A Missed Opportunity?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
89. GEORGE J, Tuli S, Monare B, Lichter K, et al
    Stage and Outcomes of Cervical Cancer With or Without HIV Infection in Botswana 2013-2020.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
90. FREIJE S, Steele EM, Robertson SE, Ishaq O Jr, et al
    Medicaid Expansion Through the Affordable Care Act and Receipt of Guideline Recommended Brachytherapy for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
91. DING S, Liu H, Wang B, Li Y, et al
    Inter- and Intrafraction Bladder and Rectum Motion in Patients With Cervical Cancer Under MR-Guided Radiotherapy on a 1.5T MR-Linac.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
92. COUSINS DF, Sanders J, Muller DA, Ward KA, et al
    Disease Characteristics and Patterns of Failure by Histologic Type for Patients Treated With Definitive Radiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
93. D'CUNHA P, Gonzalez Y, Nwachukwu CR, Hrycushko BA, et al
    Change in Image-Guided Planning Strategies Over Time Impacts Global Outcomes for Intracavitary Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
94. MORCOS M, Bhatia R, Li K, Viswanathan AN, et al
    Prospective Trial of Hydrogel Visualization and Dosimetric Effects on Rectum and Tumor Dose in Gynecologic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
95. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Toxicity Related Patients Factors and Bevasizumab Use in Patients With Locally Advanced Cervical Cancer Treated With Definitive Chemoradiation and HDR Brachytherapy Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
96. CHEN Y, Sun C, Li Q, Tang H, et al
    The Effect of Bulk Electron Density on the Accuracy of Treatment Planning for Postoperative Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
97. CHOQUE R, Aviles L, Rosas M, Suarez R, et al
    PET CT Based Stereotactic Body Radiosurgery (SBRT) in Non-Metastatic Cervical Cancer. The First Bolivian Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
98. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Racial Disparities in Time to Start of Definitive Radiation Treatment for Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
99. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Disparities and Health Access in Brachytherapy Boost Administration in Woman With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available
    
    
    
100. FAHEY M, Mills MN, Liveringhouse C, Ronica N, et al
     Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
101. SHIAO JC, Santoso A, Stuhr K, Bennett S, et al
     Gynecologic Interstitial Brachytherapy Curriculum Using a Low-Cost Phantom With Ultrasound Workshop and a Treatment Planning Workshop is Feasible and Effective.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
102. ORIAN IB, Symon Z, Appel S, Nof EL, et al
     The Impact of Radiation Therapy on Obstetric Complications in Cancer Survivors.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
103. URBAN R, Wong J, Lim P, Zhang S, et al
     Cervical Cancer Patient Reported Gastrointestinal Outcomes: Intensity/Volumetric Modulated vs. 3D Conformal Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
104. TARIQ M, Denniston KA
     EQD2 Dose Accumulation Based on Deformable Image Registration of HR-CTV, Bladder, Rectum and Bowel for Combined External-Beam Radiotherapy and Brachytherapy for Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
105. GAY C, Raphael Y, Steers J, Lu DJ, et al
     Ovarian Transposition Prior to Pelvic Radiotherapy: Spatial Distribution and Dose Volume Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
106. YEN A, Morgan HE, Wang K, Albuquerque KV, et al
     Interpretable Machine Learning Model Supported by Parallel Ensemble Learning to Predict Local Recurrence for Patients with Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
107. REIJTENBAGH DMW, Godart J, De Leeuw A, Seppenwoolde Y, et al
     A Machine-Learning Based Method for Inter-Institutional QA of MR-Based Brachytherapy Treatment Planning in Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
108. LIU C, Wang C, Hu X, Zou W, et al
     Dissecting Concurrent Chemoradiotherapy-Induced Landscape Alteration of Tumor Microenvironment in Locally Advanced Cervical Cancer at Single Cell Resolution.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
109. WANG W, Hu K, Zhang F
     Prophylactic Extended-Field Irradiation vs. Pelvic Irradiation in Cervical Cancer Patients With 2018 FIGO IIIC1 Diseases.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
110. HAN K, Fyles TW, Shek T, Croke JM, et al
     Chemoradiation With or Without Metformin in Locally Advanced Cervical Cancer: Phase II Randomized Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
111. ROBIN TP, Hu J, Jones BL, Patton TJ, et al
     Phase I Dose Escalation Clinical Trial of Stereotactic Body Radiation Therapy (SBRT) for Limited Locoregional Recurrences of Ovarian Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
112. LEUNG EW, Gladwish AP, Davidson MTM, Taggar A, et al
     Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus (SPARTACUS): A Multicenter Prospective Trial Evaluating Acute Toxicities and Patient Reported Outcomes.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
113. ZHANG Y, Liu C, Yang H, Shi M, et al
     Weekly Cisplatin vs. Triweekly Docetaxel Plus Cisplatin With Concurrent Chemoradiation in Post-Operative Treatment for Cervical Cancer With High-Risk Pathological Factors: A Randomized Controlled Phase III Trial From a Single Institution.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
114. ROGACKI K, Wray B, Donnelly ED
     Gene Expression and Mutation Analysis of Early-Stage Recurrent Endometrial Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
115. LI JY, Park HSM, Huang G, Young MR, et al
     Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal Brachytherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
116. LAKOMY DS, Wu J, Yoder AK, Hernandez M, et al
     Impact of Treatment Modality on Pelvic Floor Dysfunction for Uterine Cancer Survivors.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
117. DONOVAN E, Albuquerque KV, Mantz CA, Beriwal S, et al
     The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
118. ROVIROSA A SR, Zhang Y, Chargari C, Cooper R, et al
     3D Image-Guided Brachytherapy as Only Treatment for Stage-I Inoperable Endometrial Cancer: Retrospective Analysis of the Gynecological Cancer GEC-ESTRO Working Group.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
119. NDUMBALO J, Muya S, Nyagabona SK, Yusuph S, et al
     Continuing Education Needs Identified During the Initial Experience of Delivering 3D Conformal Radiotherapy for Cervical Cancer Patients in Tanzania.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
120. YANEY A, Mladkova N, Quick AM
     Clinical and Genomic Determinants of Survival in Ugandan Women With Cervical Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
121. BHATIA R, Ramogola-Masire D, Friebel-Klingner T, Monare B, et al
     Cervical Cancer Screening in Botswana: An Urgent Call for Guideline Change.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     October 2021
122. SPAMPINATO S, Jensen NBK, Potter R, Fokdal LU, et al
     Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future.
     Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02915.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: